BAFNA PHARMACEUTICALS
Back to All Ratios
|
BAFNA PHARMACEUTICALS Last 5 Year EBIT Growth History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| EBIT Growth(%) | 112.55 | -28.58 | -29.41 | 127.17 | -8.50 |
What is the latest EBIT Growth ratio of BAFNA PHARMACEUTICALS ?
| Year | EBIT Growth |
|---|---|
| Mar2026 | 112.55 |
| Mar2025 | -28.58 |
| Mar2024 | -29.41 |
| Mar2023 | 127.17 |
| Mar2022 | -8.50 |
How is EBIT Growth of BAFNA PHARMACEUTICALS Trending?
| Years | EBIT Growth | % Change | |
|---|---|---|---|
| Mar2026 | 112.55 | Positive | |
| Mar2025 | -28.58 | Negative | |
| Mar2024 | -29.41 | Negative | |
| Mar2023 | 127.17 | Positive | |
| Mar2022 | -8.5 | - | |
Other Financial Ratios of BAFNA PHARMACEUTICALS
| Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Growth ratio of peers of BAFNA PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BAFNA PHARMACEUTICALS | ₹1,061.5 Cr | 1.6% | 21% | 160.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,662.0 Cr | 2% | -4.4% | 3.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹257,903.0 Cr | 7.1% | 2.5% | 46.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,306.0 Cr | 1.4% | -5.7% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,699.0 Cr | 3.6% | 8% | 4.2% | Stock Analytics | |
| CIPLA | ₹111,489.0 Cr | 2% | -0.2% | -14.3% | Stock Analytics | |
BAFNA PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BAFNA PHARMACEUTICALS | 1.6% |
21% |
160.9% |
| SENSEX | 1.8% |
2.3% |
-11.9% |
You may also like the below Video Courses